CarolH(Hatch)WyshamMD(She/Her)
Endocrinology • Spokane, WADiabetes, Lipid Metabolism, Thyroid
Endocrinologist, Rockwood/Multicare Center for Diabetes and Endocrinology
Dr. Wysham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 E 5th Ave
# 4W
Spokane, WA 99202Phone+1 509-838-2531Fax+1 509-342-3451- Is this information wrong?
Summary
- Dr. Carol Wysham is an endocrinologist in Spokane, WA and is affiliated with multiple hospitals in the area, including MultiCare Deaconess Hospital and MultiCare Valley Hospital. She received her medical degree from University of Iowa Carver College of Medicine and has been in practice 37 years. She specializes in diabetes, lipid metabolism, and thyroid.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1986
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1980 - 1983
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1980
Certifications & Licensure
OR State Medical License 1982 - Present
WA State Medical License 1992 - 2026
MN State Medical License 1986 - 1993
IA State Medical License 1983 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Diabetes Recognition Program National Committee for Quality Assurance, 2012-2015
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
- Two Way Crossover Closed Loop MPC vs Control IQ Start of enrollment: 2023 Mar 13
Roles: Contact
Publications & Presentations
PubMed
- 310 citationsEfficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.Julio Rosenstock, Carol Wysham, Juan P. Frias, Shizuka Kaneko, Clare J. Lee
Lancet. 2021-07-10 - 30 citationsErratum. Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabe...Carol Wysham, Thomas Blevins, Richard Arakaki, Gildred Colon, Pedro Garcia
Diabetes Care. 2014-10-01 - 470 citationsEfficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised ...Richard M. Bergenstal, Carol Wysham, Leigh MacConell, Jaret Malloy, Brandon Walsh
Lancet. 2010-08-07
Journal Articles
- Day‐to‐Day Fasting Self‐Monitored Blood Glucose Variability Is Associated with Risk of Hypoglycaemia in Insulin‐Treated Patients with Type 1 and Type 2 Diabetes: A Pos...Gregg Gerety, Anuj Bhargava, Carol H Wysham, Diabetes, Obesity and Metabolism
Lectures
- New Treatments for Type 1 Diabetes and the Pathophysiology of Microvascular ComplicationsENDO 2019 - New Orleans, LA - 3/24/2019
- Insulin Analogs and Diabetes Technology: Past, Present, and FutureENDO 2019 - New Orleans, LA - 3/25/2019
- Master Clinician: Management of Diabetes: Selecting Therapy Based on CVD Outcomes and BeyondENDO 2019 - New Orleans, LA - 3/24/2019
- Join now to see all
Press Mentions
Once-Weekly Insulin as Effective as Daily Injections for Patients with Type 2 DiabetesSeptember 14th, 2024- Study Finds Weekly Insulin Injections as Effective for Diabetes as Daily ShotsSeptember 11th, 2024
- Once-Weekly Dose of Insulin Efsitora Alfa Delivers A1C Reduction Consistent with the Most Advanced Daily Insulin in People with Type 2 DiabetesSeptember 10th, 2024
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
MultiCare Deaconess HospitalSpokane, Washington- MultiCare Valley HospitalSpokane, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
